Suppr超能文献

青光眼中心视野异常的 10-2 和 24-2 视野检测的定性评估。

Qualitative Evaluation of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.

机构信息

From the Centre for Eye Research Australia (A.O., G.S.A., Z.W.), Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.

Hamilton Glaucoma Center (A.S.C., D.S.W., W.H.O., R.N.W., L.M.Z.), Viterbi Family Department of Ophthalmology, University of California, San Diego, La Jolla, California.

出版信息

Am J Ophthalmol. 2021 Sep;229:26-33. doi: 10.1016/j.ajo.2021.02.015. Epub 2021 Feb 21.

Abstract

PURPOSE

To examine whether glaucomatous central visual field abnormalities can be more effectively detected using a qualitative, expert evaluation of the 10-2 test compared with the topographically corresponding central 12 locations of the 24-2 test (C24-2).

DESIGN

Cross-sectional study.

METHODS

Eyes with a glaucomatous optic nerve appearance or ocular hypertension (n = 523) and healthy eyes (n = 107) were included as cases and control subjects, respectively. The 10-2 and C24-2 visual field results of all eyes were graded by 4 glaucoma specialists for the probability that central visual field abnormalities were present.

RESULTS

The sensitivity of the 10-2 and C24-2 tests for detecting the cases at 95% specificity were not significantly different (e.g., 32.2% and 31.4%, respectively, for grader 1, P = .87; all graders P ≥ .25). At 95% specificity, the pattern standard deviation values from these tests had a similar sensitivity to the qualitative evaluation for the C24-2 test for all graders (P ≥ .083), but it had a significantly higher sensitivity than the qualitative evaluation for the 10-2 test for 3 graders (P ≤ .016).

CONCLUSIONS

The similarity in performance of the 10-2 and C24-2 test suggests that the increased sampling density of the former does not significantly improve the detection of central visual field abnormalities, even when based on expert assessment. These findings should not be taken to mean that the 10-2 test is not useful, but it underscores the need for its utility to be clearly established before incorporating it as routine glaucoma standard of care.

摘要

目的

研究与传统的 24-2 测试中具有拓扑对应关系的中央 12 个部位(C24-2)相比,通过对 10-2 测试的定性、专家评估,是否能更有效地检测出青光眼的中央视野异常。

设计

横断面研究。

方法

将视神经外观异常或高眼压的眼(n=523)和正常眼(n=107)分别作为病例和对照组纳入研究。由 4 位青光眼专家对所有眼的 10-2 和 C24-2 视野结果进行分级,以评估中央视野异常存在的概率。

结果

在 95%特异性下,10-2 和 C24-2 检测病例的敏感性没有显著差异(例如,第 1 位分级师的敏感性分别为 32.2%和 31.4%,P=.87;所有分级师 P≥.25)。在 95%特异性下,这些测试的模式标准差值与 C24-2 测试的定性评估对于所有分级师的敏感性相似(P≥.083),但对于 3 位分级师,其敏感性明显高于 10-2 测试的定性评估(P≤.016)。

结论

10-2 和 C24-2 测试的性能相似,表明前者的采样密度增加并没有显著提高中央视野异常的检测率,即使是基于专家评估。这些发现不应被视为 10-2 测试没有用,但它强调在将其纳入常规青光眼标准护理之前,需要明确其效用。

相似文献

1
Qualitative Evaluation of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.
Am J Ophthalmol. 2021 Sep;229:26-33. doi: 10.1016/j.ajo.2021.02.015. Epub 2021 Feb 21.
2
Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.
Am J Ophthalmol. 2018 Dec;196:10-17. doi: 10.1016/j.ajo.2018.08.010. Epub 2018 Aug 10.
3
Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.
Ophthalmol Glaucoma. 2019 Mar-Apr;2(2):95-102. doi: 10.1016/j.ogla.2019.01.003. Epub 2019 Jan 14.
4
An Evaluation of a New 24-2 Metric for Detecting Early Central Glaucomatous Damage.
Am J Ophthalmol. 2021 Mar;223:119-128. doi: 10.1016/j.ajo.2020.07.045. Epub 2020 Aug 7.
5
Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1173-80. doi: 10.1167/iovs.06-0561.
7
Combining structural and functional testing for detection of glaucoma.
Ophthalmology. 2006 Sep;113(9):1593-602. doi: 10.1016/j.ophtha.2006.06.004.

引用本文的文献

1
High-Resolution Microperimetry for Detecting Glaucomatous Damage: A Prospective Evaluation of Performance.
Clin Exp Ophthalmol. 2025 Aug;53(6):602-610. doi: 10.1111/ceo.14528. Epub 2025 Mar 24.
2
Transformer-Based Deep Learning Prediction of 10-Degree Humphrey Visual Field Tests From 24-Degree Data.
Transl Vis Sci Technol. 2024 Aug 1;13(8):11. doi: 10.1167/tvst.13.8.11.
4
Comparison of 10-2 and 24-2 Perimetry to Diagnose Glaucoma Using OCT as an Independent Reference Standard.
Ophthalmol Glaucoma. 2023 Mar-Apr;6(2):187-197. doi: 10.1016/j.ogla.2022.08.017. Epub 2022 Sep 7.
5
Association of Visual Field Pattern Reversal with Paracentral Visual Field Loss.
Ophthalmol Glaucoma. 2022 May-Jun;5(3):353-358. doi: 10.1016/j.ogla.2021.10.009. Epub 2021 Oct 21.
6
Agreement between Compass Fundus Perimeter New Grid and 10-2 Testing Protocols for Detecting Central Visual Field Defects.
Ophthalmol Glaucoma. 2022 Mar-Apr;5(2):179-187. doi: 10.1016/j.ogla.2021.07.006. Epub 2021 Jul 20.

本文引用的文献

1
Value of 10-2 Visual Field Testing in Glaucoma Patients with Early 24-2 Visual Field Loss.
Ophthalmology. 2021 Apr;128(4):545-553. doi: 10.1016/j.ophtha.2020.08.033. Epub 2020 Sep 6.
2
An Evaluation of a New 24-2 Metric for Detecting Early Central Glaucomatous Damage.
Am J Ophthalmol. 2021 Mar;223:119-128. doi: 10.1016/j.ajo.2020.07.045. Epub 2020 Aug 7.
3
Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.
Ophthalmol Glaucoma. 2019 Mar-Apr;2(2):95-102. doi: 10.1016/j.ogla.2019.01.003. Epub 2019 Jan 14.
4
Specificity of various cluster criteria used for the detection of glaucomatous visual field abnormalities.
Br J Ophthalmol. 2020 Jun;104(6):822-826. doi: 10.1136/bjophthalmol-2019-314593. Epub 2019 Sep 17.
5
Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.
Am J Ophthalmol. 2018 Dec;196:10-17. doi: 10.1016/j.ajo.2018.08.010. Epub 2018 Aug 10.
6
Effectiveness of a Qualitative Approach Toward Evaluating OCT Imaging for Detecting Glaucomatous Damage.
Transl Vis Sci Technol. 2018 Jul 18;7(4):7. doi: 10.1167/tvst.7.4.7. eCollection 2018 Jul.
7
What rates of glaucoma progression are clinically significant?
Expert Rev Ophthalmol. 2016;11(3):227-234. doi: 10.1080/17469899.2016.1180246. Epub 2016 May 13.
8
24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma.
Ophthalmology. 2017 Oct;124(10):1449-1456. doi: 10.1016/j.ophtha.2017.04.021. Epub 2017 May 24.
9
Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.
JAMA Ophthalmol. 2017 Jul 1;135(7):742-747. doi: 10.1001/jamaophthalmol.2017.1396.
10
Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients.
Ophthalmology. 2017 Jun;124(6):786-792. doi: 10.1016/j.ophtha.2017.01.027. Epub 2017 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验